7723f502_s___Medical_Oncologists___ESMO__Topic
[Date] 01 Apr 2014 [Title] PRESTIGE Study: Goserelin Given Every 12 vs. 4 Weeks in Premenopausal Women With ER-Positive Advanced Breast Cancer [Topic] 
Breast cancer - Anticancer agents & Biologic therapy
Oncology News | Medical Oncologists | ESMO